Clinical Study
Morinda citrifolia (Noni) as an Anti-Inflammatory Treatment in Women with Primary Dysmenorrhoea: A Randomised Double-Blind Placebo-Controlled Trial
Table 2
(a) Difference in haematological investigations between placebo and noni. (b) Bleeding scores and haematological results.
| (a) |
| | Variable | Mean difference placebo versus Noni (95% CI) | P value |
| | Haemoglobin (g/dL) | −0.08 (−0.41 to 0.26) | 0.6 | | Packed cell volume | 0.005 (−1.21 to 1.22) | 0.9 | | ESR (mm/sec) | 0.79 (0.6 to 0.9) | <0.02 |
|
|
| (b) |
| | Variables | Placebo | Noni | | Mean (SD) | Mean (SD) |
| | Hb before study (g/dL) | 11.68 (1.39) | 11.52 (1.33) | | Hb after study (g/dL) | 11.75 (1.10) | 11.74 (1.01) | | Hb difference (g/dL) | 0.07 (0.85) | 0.22 (0.78) | | ESR before study (mm/sec) | 15.29 (13.07) | 18.94 (14.46) | | ESR after study (mm/sec) | 13.47 (9.82) | 10.56 (6.66) | | Bleeding score before | 88.42 (54.76) | 99.31 (70.69) | | Bleeding score after second cycle | 85.00 (50.37) | 91.43 (70.37) | | Bleeding score after third cycle | 70.93 (54.39) | 87.70 (59.70) | | Bleeding score difference | 4.18 (43.72) | 7.19 (30.41) |
|
|
